Showing results (1041-1050 of 1,556) with videos related to

Sort By:
Pageof 156
JCO Oncology Practice|November 12, 2024
Administrative Aspects of Molecular Diagnostics-Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment ModelsLalan Wilfong, Lauren Baggett, Philip Reena, et al.
JCO Oncology Practice|October 31, 2024
Willingness of Women at Increased Risk of Breast Cancer to Participate in Prevention TrialsCecilia N Mastrogiacomo, Alexa Courtepatte, Anne Moyer, et al.
JCO Oncology Practice|November 8, 2024
Association of Limited Health Literacy With Frailty, Health-Related Quality of Life, and Health Care Utilization Among Older Adults With Cancer: The Cancer and Aging Resilience Evaluation RegistrySrihitha Padamatinti, Mackenzie E Fowler, Coryn Stephenson, et al.
JCO Oncology Practice|July 15, 2024
Electronic Patient-Reported Outcome-Driven Symptom Management by Oncology Pharmacists in a Majority-Minority Population: An Implementation StudyAlexandre Chan, Ding Quan Ng, Daniela Arcos, et al.
JCO Oncology Practice|July 15, 2024
Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview SurveySteven Leonard, Emma Helstrom, Andres Correa, et al.
JCO Oncology Practice|July 11, 2024
Material, Psychological, and Behavioral Financial Hardship Among Lesbian, Gay, and Bisexual Cancer Survivors in the United StatesAustin R Waters, Stephanie B Wheeler, Kelly R Tan, et al.
JCO Oncology Practice|August 16, 2024
Selecting Immune Checkpoint Inhibitor Side Effects for Real-Time Monitoring in Routine Cancer Care: A Modified Delphi StudyJulia Lai-Kwon, Michael Jefford, Stephanie Best, et al.
JCO Oncology Practice|July 30, 2024
What Is the Value of Palliative Care for Inpatients With Cancer?Ramy Sedhom, Thomas J Smith, J Brian Cassel, et al.
JCO Oncology Practice|June 27, 2024
Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients With Advanced Neuroendocrine TumorsReut Halperin, Amit Tirosh
JCO Oncology Practice|June 25, 2024
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS LymphomaLauren R Schaff, Dean Carlow, Ryan Schofield, et al.
Pageof 156